Literature DB >> 6529539

Monitoring free plasma concentrations of phenytoin.

G M Peterson, S McLean.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6529539      PMCID: PMC1463684          DOI: 10.1111/j.1365-2125.1984.tb02576.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  7 in total

1.  Variability of phenytoin protein binding in epileptic patients.

Authors:  H J DeMonaco; L M Lawless
Journal:  Arch Neurol       Date:  1983-08

2.  Plasma protein binding of phenytoin in 100 epileptic patients.

Authors:  G M Peterson; S McLean; S Aldous; R J Von Witt; K S Millingen
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

Review 3.  Plasma protein binding of phenytoin in health and disease: relevance to therapeutic drug monitoring.

Authors:  E Perucca
Journal:  Ther Drug Monit       Date:  1980       Impact factor: 3.681

4.  Two-fold interindividual variation in plasma protein binding of phenytoin in patients with epilepsy.

Authors:  N Barth; G Alván; O Borgå; F Sjöqvist
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

5.  Frequency distribution of free warfarin and free phenytoin fraction values in serum of healthy human adults.

Authors:  A Yacobi; T Lampman; G Levy
Journal:  Clin Pharmacol Ther       Date:  1977-03       Impact factor: 6.875

6.  Should we routinely measure free plasma phenytoin concentration?

Authors:  E M Rimmer; D C Buss; P A Routledge; A Richens
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

7.  Interindividual differences of protein binding in man.

Authors:  H Walther; F P Meyer
Journal:  Int J Clin Pharmacol Biopharm       Date:  1979-10
  7 in total
  1 in total

Review 1.  Free drug concentration monitoring in clinical practice. Rationale and current status.

Authors:  C K Svensson; M N Woodruff; J G Baxter; D Lalka
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.